Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy

References

• Kuruvilla J, Keating A, Crump M. How I treat relapsed and refractory Hodgkin lymphoma. Blood 2011;117:4208–4217.
   PubMed Web of Science ®Google Scholar
• Follows GA, Ardeshna KM, Barrington SF, et al. Guidelines for the first line management of classical Hodgkin lymphoma. Br J Haematol 2014;166:34–49.
   PubMed Web of Science ®Google Scholar
• Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506–1514.
   PubMed Web of Science ®Google Scholar
• Franklin J, Paulus U, Lieerz D, et al. Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? Annals Oncol 2000;11:617–623.
   PubMed Web of Science ®Google Scholar
• Moccia AA, Donaldson J, Chhanabhai M, et al. International Prognostic Score (IPS) in advanced-stage Hodgkin's lymphoma; altered utility in the modern era. J Clin Oncol 2012;30:3383–3388.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361–1392.
   PubMed Web of Science ®Google Scholar
• Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010;362: 875–885.
   PubMed Web of Science ®Google Scholar
• Steidl C, Connors JM, Gascoyne RD. Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol 2011;29:1812–1826.
   PubMed Web of Science ®Google Scholar
• Scott DW, Chan FC, Hong F, et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J Clin Oncol 2013;31:692–700.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Ristow K, Colgan JP, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica 2011;97:262–269.
   PubMed Web of Science ®Google Scholar
• Koh YW, Kang HJ, Park C, et al. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. Oncologist 2012;17:871–880.
   PubMed Web of Science ®Google Scholar
• Matzner Y, Konijn AM, Hershko C. Serum ferritin in hematologic malignancies. Am J Hematol 1980;9:13–22.
   PubMed Web of Science ®Google Scholar
• Zhang XZ, Su AL, Hu MQ, et al. Elevated serum ferritin levels in patients with hematological malignancies. Asian Pac J Cancer Prev 2014;15:6099–6101.
   PubMed Web of Science ®Google Scholar
• Yamazaki E, Tomita N, Koyama S, et al. Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type. Med Oncol 2014;31:149.
   PubMed Web of Science ®Google Scholar
• Yoh KA, Lee HS, Park LC, et al. The prognostic significance of elevated levels of serum ferritin before chemotherapy in patients with non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk 2014; 14:43–49.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Massini G, Giachelia M, et al. Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol 2010;28:2538–2543.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Giachelia M, Cuccaro A, et al. Iron in Hodgkin's lymphoma. Crit Rev Oncog 2013;18:463–469.
   PubMedGoogle Scholar
• Dörner MH, Abel U, Fritze D, et al. Serum ferritin in relation to the course of Hodgkin's disease. Cancer 1983;52:2308–2312.
   PubMed Web of Science ®Google Scholar
• Bezwoda WR, Derman DP, Bothwell TH, et al. Serum ferritin and Hodgkin's disease. Scand J Haematol 1985;35:505–510.
   PubMedGoogle Scholar
• Swerdlow SH, Campo E, Harris N, et al. WHO Classification of tumours of haematopoietic and lymphoid Tissues, 4th ed. Lyon, France: IARC; 2008.
   Google Scholar
• Cheson BD, Pfistner B, Juweis ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457–481.
   Web of Science ®Google Scholar
• Peto R, Pike MC. Conservatism of the approximation Σ(O-E)2/E in the log-rank test for survival data or tumor incidence data. Biometrics 1973;29:579–584.
   PubMed Web of Science ®Google Scholar
• Cox DR. Regression models and life-tables. J Roy Stat Soc Series B 1972;34:187–202.
   Web of Science ®Google Scholar
• Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002;99:4283–4297.
   PubMed Web of Science ®Google Scholar
• Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783–788.
   PubMed Web of Science ®Google Scholar
• Guisado-Vasco P, Arranz-Saez R, Canales M, et al. Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series. Leuk Lymphoma 2012;53:812–819.
   PubMed Web of Science ®Google Scholar
• Recalcati S, Invernizzi P, Arosio P, Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 2008;30:84–89.
   PubMed Web of Science ®Google Scholar
• Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: Past, present and future. Biochim Biophys Acta 2010;1800:760–769.
   PubMed Web of Science ®Google Scholar
• Diepstra A, van Imhoff GW, Schaapveld M, et al. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol 2009;27:3815–3821.
   PubMed Web of Science ®Google Scholar